AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares

AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares

• AEON Biopharma issued 4,696,102 Class A shares in a partial over-allotment exercise tied to its July 15 public offering.
• The transaction delivered about $1.5 million in gross proceeds, about $1.4 million net of underwriting discounts and commissions.
• Lake Street had already fully exercised the over-allotment option for two-year milestone warrants, five-year milestone warrants covering 6,403,290 shares or pre-funded warrants.